Atlas FDA

Altaviva™ Implantable Neurostimulator

FDA premarket approval P240011/S001 · decided 2025-10-17

Approval details

PMA number
P240011
Supplement
S001
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Altaviva™ Implantable Neurostimulator
Generic name
Stimulator, tibial, electrical, implantable, for urinary incontinence
Applicant
Medtronic Neuromodulation
Date received
2025-09-19
Decision date
2025-10-17
Days to decision
28 days
Decision code
OK30
Product code
QPT
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Minneapolis, MN
Statement
approval to implement three manufacturing changes impacting the hybrid electronic module subassemblies including hybrid wafer visual inspection update for foreign material, hybrid final visual inspection criteria update, and hybrid manufacturing new vapor degreasing solvents

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
SureTune4 Software (DEN210003)Medtronic Neuromodulation2021-08-23